Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New treatments for ALL in active development at major research institute

May 16, 2000

BNP-7787 to enter phase III clinical trials as chemoprotectant

May 16, 2000

Lambda synthesizes photosensitizers with enhanced activity compared to Photofrin

May 16, 2000

Isolation, structure and biological activity of new Cdc25B tyrosine phosphatase inhibitors

May 12, 2000

Survival results promising in phase II study of 81C6 MAb in patients with recurrent brain tumors

May 12, 2000

PF-1201: new antitumor antibiotic selective for tumor gene-transformed cell lines

May 12, 2000

Kinase inhibitors under evaluation at major German pharmaceutical laboratory

May 11, 2000

Antitumor agents from American Cyanamid act by inhibiting PTKs

May 11, 2000

HMW endostatins for treatment and diagnosis of tumors disclosed by Haemopep

May 11, 2000

CDD and ICRT to collaborate on anticancer drug development

May 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...